Metsera
Metsera is a clinical-stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
About Metsera
Metsera is a biotechnology company that develops and manufactures therapies. The company's focus is on nutrient-stimulated hormone therapies for obesity and related conditions. Its portfolio includes both injectable and oral therapeutic candidates.
Company Facts
- Headquarters
- New York
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00051_00100
- Funding Stage
- m_and_a
- Total Funding
- $505,000,000
- Last Funding Type
- series_b
- Last Funding Date
- 2024-11-13
- Website
- metsera.com
Industries & Categories
Biopharma, Health Care, Medical, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/metsera-18081 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.